What was Tci Gene Inc.’s price range in the past 12 months?
Tci Gene Inc. lowest stock price was TWD 32.30 and its highest was TWD 41.05 in the past 12 months.
What is Tci Gene Inc.’s market cap?
Tci Gene Inc.’s market cap is TWD 916.79M.
When is Tci Gene Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Tci Gene Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Tci Gene Inc. pay dividends?
Tci Gene Inc. pays a ― dividend of TWD 2 which represents an annual dividend yield of 5.77%. See more information on Tci Gene Inc. dividends here
What is Tci Gene Inc.’s EPS estimate?
Tci Gene Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tci Gene Inc. have?
Tci Gene Inc. has 26,458,520 shares outstanding.
Which hedge fund is a major shareholder of Tci Gene Inc.?
Currently, no hedge funds are holding shares in TW:6879
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tci Gene Inc.
TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized preventative healthcare solutions. The company offers an extensive range of genetic screenings, including tests for nutrient metabolism, weight management, and specific G2 and ACE2 markers. Its diverse product portfolio encompasses dietary supplements, skincare items, anti-aging treatments, products designed to support children's development, and solutions targeting Alzheimer's disease. Additionally, TCI GENE provides specialized serums for DNA typing and offers professional nutrition counseling services.